Controlled-release of apatinib for targeted inhibition of osteosarcoma by supramolecular nanovalve-modi ed mesoporous silica

HIGHLIGHTS

  • who: February and colleagues from the Shanxi Medical University, China have published the article: Controlled-release of apatinib for targeted inhibition of osteosarcoma by supramolecular nanovalve-modi ed mesoporous silica, in the Journal: (JOURNAL)
  • how: These results showed that the HACA nanoparticles could reduce the migration ability of 143B cells which will effectively prevent the metastasis of tumor cells. After co-incubation of HACA-Ce6 with 143B cells the fluorescence was observed under CLSM and the results showed that HACA-Ce6 nanoparticles were more easily frontiersin.org 10.3389/fbioe.2023.1135655

SUMMARY . . .

 

Logo ScioWire Beta black

If you want to have access to all the content you need to log in!

Thanks :)

If you don't have an account, you can create one here.

 

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?